These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29376206)

  • 21. Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.
    Ahn SS; Hong SH; Park Y; Jung SM; Song JJ; Park YB; Lee SW; Park SG
    Clin Exp Rheumatol; 2018; 36(4):533-539. PubMed ID: 29352840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
    Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
    Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study.
    Rasheed AB; Daoud MS; Gorial FI
    Reumatismo; 2017 Dec; 69(4):170-174. PubMed ID: 29320843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of adenosine deaminase in mothers who have conceived a fetus with central nervous system malformations.
    Engin-Ustün Y; Ustün Y; Sezgin B; Karabulut AB; Kiran TR; Kafkasli A
    J Perinat Med; 2007; 35(5):399-402. PubMed ID: 17605595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum adenosine deaminase activity in monitoring disease activity and response to therapy in severe psoriasis.
    Erbagci Z; Erbagci AB; Köylüoglu O; Tuncel AA
    Acta Medica (Hradec Kralove); 2006; 49(2):101-4. PubMed ID: 16956117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of serum adenosine deaminase in pulmonary tuberculosis.
    Saini V; Lokhande B; Jaswal S; Aggarwal D; Garg K; Kaur J
    Indian J Tuberc; 2018 Jan; 65(1):30-34. PubMed ID: 29332644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
    Zhang Q; Li X; Yin X; Wang H; Fu C; Wang H; Li K; Li Y; Zhang X; Liang H; Li K; Li H; Qiu Y
    Rheumatology (Oxford); 2021 Feb; 60(2):598-606. PubMed ID: 32259244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
    Yang J; Li Q; Yang X; Li M
    Lupus; 2016 Apr; 25(5):513-9. PubMed ID: 26678441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined evaluation of adenosine deaminase level and histopathological findings from pleural biopsy with Cope's needle for the diagnosis of tuberculous pleurisy.
    Behrsin RF; Junior CT; Cardoso GP; Barillo JL; de Souza JB; de Araújo EG
    Int J Clin Exp Pathol; 2015; 8(6):7239-46. PubMed ID: 26261621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting role of Myc-induced nuclear antigen 53 in determining the development and severity of systemic lupus erythematosus.
    Zamani B; Dadgostar E; Akbari H; Motedayyen H; Nikoueinejad H
    Front Immunol; 2024; 15():1370738. PubMed ID: 38863713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
    Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
    Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus.
    Xie S; Chen X
    Medicine (Baltimore); 2018 Sep; 97(39):e12342. PubMed ID: 30278511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
    Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
    Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of adenosine deaminase to differentiate exudates and transudates.
    Jadhav AA; Bardapurkar JS
    Indian J Physiol Pharmacol; 2007; 51(2):170-4. PubMed ID: 18175662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum adenosine deaminase levels in pancreatic diseases.
    Ibiş M; Köklü S; Yilmaz FM; Başar O; Yilmaz G; Yüksel O; Yildirim E; Oztürk ZA
    Pancreatology; 2007; 7(5-6):526-30. PubMed ID: 17901713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
    Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
    Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.